top of page

MHA112
Antibody Drug Conjugate
MHA112 is an antibody that has the ability to target primary solid tumors while simultaneously targeting any metastases in the draining lymph node and secondary tumors.
MHA112: Products
MHA112
Antibody Drug Conjugate
MHA112 targets a specific protein only expressed in specialized venules contained in the lymphatic system. These specialized venules have been shown to proliferate in and around solid tumors, expressing the same protein targeted by MHA112.

MHA112: Products

MHA112
Antibody Drug Conjugate
By conjugating MHA112 to powerful active pharmaceuticals, we can create a highly effective treatment for primary cancer tumors as well as their metastases
MHA112: Products
MHA112: Products
bottom of page